Factor VIII, a non-covalent heterodimer comprised of a heavy chain (A1-A2-B domains) and light chain (A3-C1-C2 domains), circulates as an inactive procofactor in complex with von Willebrand factor. Metal ions are critical to the integrity of factor VIII, with Cu and Ca ions stabilizing the heterodimer and generating the active conformation, respectively. Activation of factor VIII catalyzed by thrombin appears dependent upon interactions with both anion-binding exosites I and II, and converts the heterodimer to the active cofactor, factor VIIIa. This protein, comprised of A1, A2, and A3-C1-C2 subunits, is labile due to weak affinity of the A2 subunit. Association of factor VIIIa with factor IXa to form the intrinsic factor Xase complex is membrane-dependent and involves multiple inter-protein contacts that remain poorly characterized. This complex catalyzes the conversion of factor X to factor Xa, a reaction that is essential for the propagation phase of coagulation. The role of factor VIIIa in this complex is to increase the catalytic efficiency for factor Xa generation by several orders of magnitude. Mechanisms for the down-regulation of factor Xase focus upon inactivation of the cofactor and include dissociation of the A2 subunit as well as activated protein C-catalyzed proteolysis.
Introduction
Factor VIII serves as a cofactor for the serine proteinase factor IXa in the conversion factor X to factor Xa during the propagation phase of blood coagulation. The essential role of factor VIII in coagulation is indicated by hemophilia A, the most common of the severe bleeding disorders, which results from a defect or a deficiency in this protein.Although the primary structure of factor VIII is known, and homologies with similar proteins have produced model structures, little information from high-resolution structures of factor VIII is available. Similarly, regions of factor VIII critical for cofactor function and specific mechanisms for catalytic rate enhancement remain poorly understood. This review focuses on recent information related to understanding the structure and function of this essential blood coagulation factor.
Factor VIII Structure
Factor VIII is synthesized primarily by liver sinusoidal endothelial cells [1] as a large (~300 kDa; 2332 residues) single chain protein [2, 3] . Internal sequence homologies indicate a triplicated "A" domain homologous to the A domains in factor V and ceruloplasmin, a duplicated "C" domain, and a large "B" domain that is not homologous to other known structures [2, 4] . Segments (~30-40 amino acids; designated by a lowercase "a") possessing a high concentration of acidic residues directly follow the A1 (residues 337-372) and A2 domains (residues 711-740) and precede the A3 domain (residues 1649-1689). The domain structure of factor VIII is ordered as: (NH 2 ) A1-a1-A2-a2-B-a3-A3-C1-C2 (COOH) (Figure 1 ). N-linked glycosylation, which heavily modifies the B domain as well as several sites in the A1 domain, appears dispensable for factor VIII activity. Post-translational modification includes sulfation of specific tyrosine residues in the acidic ("a") regions. Sulfated tyrosine residues in the a2 and a3 acidic segments contribute to cofactor function and von Willebrand factor (VWF) binding, respectively [5] .
Structural information on factor VIII is limited. Homology modeling of the A domains based upon the crystal structure of ceruloplasmin [6] , which shows ~35% identity with factor VIII A domains, has provided useful information for predicting interactive sites for ligands and macromolecules, as well as mapping mutations. The x-ray structure of the C2 domain [7] represents the only current high-resolution structure for a factor VIII domain and provides a mechanism for cofactor binding to membranes that involves both hydrophobic and electrostatic interactions. Studies on 2-D crystals of factor VIII bound to phospholipids have yielded gross information (at 15 Å resolution) on inter-domain orientation and have been employed to construct a 5-domain model (A plus C domains) of factor VIII [8] . The recent x-ray structure of the bovine factor Va A1/A3-C1-C2 dimer [9], obtained following cleavage of factor Va by activated protein C, may provide added insights into the interactions of these domains in factor VIIIa, because models derived from this structure would be superior to the current models derived from homology to ceruloplasmin A domains.
Factor VIII circulates as a series of heterodimers formed as a result of proteolysis at the B-A3 junction plus additional cleavages at sites within the B domain (see Ref.
[10] for review). Thus factor VIII contains a constant sized light chain, composed of the A3-C1-C2 domains, and a heavy chain, minimally represented by the A1-A2 domains but variable in size due to the presence of some or all of the contiguous B domain (Figure 1) . Binding of the 2 chains is noncovalent and requires a metal ion-dependent linkage, with the residues responsible contained within the A1 and A3 domains. This metal ion is likely copper, and 1 mol of copper ion (Cu+, [11]) has been identified in factor VIII [12] . Reconstitution of isolated factor VIII chains showed that Cu ions significantly increase the inter-chain affinity [13] . Three putative Cu-coordination sites exist in factor VIII [6], a type 1 site in the A1 (His257/Cys310/His315/Met320) and A3 (His1954/ Cys2000/His205/Met2010) domains and a type 2 site that spans residues in the A1 (His99) and A3 (His1957) domains. Sites for Cu ion binding in factor VIII have not been rigorously determined and the location of the metal ion(s) remains controversial. One study examining the activity of transiently expressed factor VIII molecules possessing point mutations in the putative sites suggested a role for the type 1 site in the A1 domain in coordinating the Cu ion [11] . However, other studies assessing the reconstitution of factor VIII activity employing fluorophore-modified factor VIII at Cys residues predicted to participate in Cu binding (Cys310 and Cys2000) supports a role for the type 2 site in promoting chain association [13] .
Although Cu ions facilitate inter-chain affinity, Ca 2+ [13, 14] , whereas Asp116 and Asp125 may also contribute to Mn 2+ coordination [17] . Recently, a novel point mutation within this A1 domain Ca 2+ binding site was described that possessed ~2-fold greater specific activity than wild type factor VIII [18] . The basis for this gain-of-function is not clear but may relate to the ~4-fold enhanced affinity for factor IXa observed on physiological membrane surfaces. This observation reinforces the role for Ca 2+ sites in modulating cofactor function.
Factor VIII circulates in noncovalent complex with VWF, a large, multimeric protein comprised of identical ~220 kDa subunits. Factor VIII binds VWF in a high affinity interaction (Kd ~0.3 nM) mediated by residues in the factor VIII light chain. Critical sites for this interaction have been localized to the N-terminal acidic region preceding the A3 domain (a3, residues 1649-1689) and the C2 domain (see Ref.
[19] for review). Recent insights provided by the factor VIII model suggest that the a3 segment and the C1 and C2 domains form an extended surface for interaction with VWF [20] . Interactive residues for binding VWF also appear to overlap with those required for the association of factor VIII with anionic phospholipids, thus blocking premature association with thrombogenic surfaces. The association of factor VIII in this complex results in several positive attributes that include increased circulatory half-life and protection from proteolysis. This latter attribute, largely a result of inhibition of the interaction of factor VIII with phospholipid surfaces as well as direct competition with protease binding sites [21] , is particularly relevant in that it limits catalysis by surface-dependent
